← All organizations
Highest phase reached
Phase 3
First clinical trial
May 15, 2019Last known activity
Mar 15, 2026
Timeline
1990s
- Jan 1, 1991
Fundación GECP— Founded
Drugs by trial phase (20 distinct, 16 trials)
Phase 3 (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (23)
- NCT07247786Lead sponsorPhase 2Mar 15, 2026
- NCT07242547Lead sponsorPhase 2Dec 25, 2025
- NCT06917573Lead sponsorPhase 2Jul 29, 2025
- NCT06917573OfficialPhase 2Jul 29, 2025
- NCT07153445Lead sponsorPhase 2Jul 8, 2025
- NCT06431633Lead sponsorPhase 2Oct 1, 2024
- NCT05684276Study chairPhase 2May 12, 2023
- NCT05684276Lead sponsorPhase 2May 12, 2023
- NCT05384015Lead sponsorPhase 2Nov 7, 2022
- NCT05398094Lead sponsorPhase 2Mar 21, 2022
- NCT05398094Study chairPhase 2Mar 21, 2022
- NCT05012254Overall official - principal investigatorPhase 2Dec 15, 2021
- NCT05012254Lead sponsorPhase 2Dec 15, 2021
- NCT05005429Overall official - principal investigatorPhase 2Sep 20, 2021
- NCT05005429Lead sponsorPhase 2Sep 20, 2021
Details
- Founded
- Barcelona, ES Jan 1, 1991
- Last known activity
- Mar 15, 2026